Feedback / Questions
NurOwn (MSC-NTF) - BrainStorm Cell Therap
https://www.prnewswire.com/news-releases/brainstorm-cell-therapeutics-announces-fda-advisory-committee-meeting-to-review-nurown-biologics-license-application-scheduled-for-september-27-2023-301843416.html
Jun 6, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next